MedPath

Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia

Not Applicable
Recruiting
Conditions
Dysphagia
Aspiration
Apparent Life Threatening Event (ALTE)
Brief Resolved Unexplained Event (BRUE)
Interventions
Dietary Supplement: Moderately thickened liquid swallows
Dietary Supplement: Thin liquid swallows
Dietary Supplement: Slightly thickened liquid swallows
Dietary Supplement: Mildly thickened liquid swallows
Registration Number
NCT04504227
Lead Sponsor
Boston Children's Hospital
Brief Summary

This study will examine the effects of varying liquid viscosity on swallow physiology in infants with oropharyngeal dysphagia and brief resolved unexplained event (BRUE) and other children with dysphagia that would be at risk for symptoms of swallow dysfunction.

Detailed Description

Infants with oropharyngeal dysphagia and in particular brief resolved unexplained events (BRUE) are a significant driver of pediatric health care expenditure since the mechanism for their swallow dysfunction is incompletely understood and therefore frequently goes unrecognized and untreated. We hypothesize that infants with oropharyngeal dysphagia and BRUE have measurable differences in swallowing physiology to explain their symptoms of cyanotic choking spells, that these differences can be quantified using pharyngeal high resolution impedance-manometry compared to videofluoroscopic swallow study results, and that this swallowing dysfunction can be safely corrected with a change of formula viscosity. Through this research project, we will systematically investigate the effects of thickened feedings on swallow function in infants with dysphagia and BRUE and perform detailed physiology studies on pharyngeal and esophageal motility as critical mediators of improved outcomes.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age 0 to 21 years
  • Admitted to Boston Children's Hospital after experiencing first lifetime BRUE, or with dysphagia symptoms such that they would be at risk for BRUE or other symptoms of swallowing difficulty
  • Have had videofluoroscopic swallow study performed or might have future videofluoroscopic swallow study performed.
Exclusion Criteria
  • Any pre-existing medical diagnoses that exclude brief resolved unexplained event diagnosis including seizure disorders and cyanotic congenital heart disease
  • Any nasal/pharyngeal/esophageal anomalies that might affect safe placement of the pharyngeal motility catheter
  • Children fed exclusively by enteral tube
  • Allergy to rice cereal or Gelmix thickener, which will be used to adjust liquid viscosity

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Moderately thick liquid swallowsModerately thickened liquid swallowsModerately thick liquid swallows of formula thickened with rice cereal or breastmilk or other liquid thickened with Gelmix
Thin liquid swallowsThin liquid swallowsThin liquid swallows of formula or breastmilk or other liquid
Slightly thick liquid swallowsSlightly thickened liquid swallowsSlightly thick liquid swallows of formula thickened with rice cereal or breastmilk or other liquid thickened with Gelmix
Mildly thick liquid swallowsMildly thickened liquid swallowsMildly thick liquid swallows of formula thickened with rice cereal or breastmilk or other liquid thickened with Gelmix
Primary Outcome Measures
NameTimeMethod
Swallow risk indices for thin vs mildly thick vs slightly thick liquids30 minutes

We will calculate swallow risk index (SRI) from impedance-manometry results to compare mean SRI with thin liquids and thickened liquids for subjects with aspiration compared to mean SRI for thin liquids and thickened liquids in subjects without aspiration.

Secondary Outcome Measures
NameTimeMethod
Impedance-Manometry Swallow Physiology Metrics30 minutes

We will measure swallow physiology metrics from impedance-manometry results, including post-swallow impedance ratio, to compare these parameters with thin liquids between subjects with and without aspiration and with varied liquid consistencies within subjects.

Trial Locations

Locations (1)

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath